Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TurboMed Orthotics is a private Canadian medical device company focused on external ankle-foot orthoses for people with foot drop and related gait impairment. Its flagship XTERN product family is an externally mounted, modular AFO system designed to provide dorsiflexion assistance while preserving ankle range of motion and allowing use across multiple types of footwear. The company markets products directly and through clinics and distributors, with stated distribution across more than 30 countries. TurboMed appears to operate as a commercial-stage orthotics manufacturer rather than a drug-development biotech company, with offerings that include adult, pediatric, and trial-fit variants plus accessories and replacement parts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TurboMed Orthotics.